Association between adiposity measures, demo-Graphic and biochemical variables with creactive protein serum levels in rural population.;Associação entre medietas de adiposidade, varláveis demográficas e bioquímicas com os níveis séricos de proteína c-reativa em população rural

Archivos Latinoamericanos de Nutricion

Volumn 59, Issue 1, 2009, Pages 54-60

  Fernandes, Amanda Carlo ^a   Gazzinelli, Andrea ^a   Velásquez Meléndez, Gustavo ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adipose tissue; Anthropometry; C reactive protein; Cardiovascular diseases; Obesity; Risk factors; Rural population

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; BRAZIL; CARDIOVASCULAR DISEASE; CHEMISTRY; EPIDEMIOLOGY; FEMALE; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; OBESITY; PHYSIOLOGY; RURAL POPULATION; SEX RATIO; STATISTICS;

ADIPOSE TISSUE; ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; RURAL POPULATION; SEX DISTRIBUTION; YOUNG ADULT;

EID: 68849120222     PISSN: 00040622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007; 29:1-5.
2. Rain J, Vio F, Albala C. Obesity trends and determinant factors in Latin América. Cad Saúde Publica. 2003; 19 Suppl 1:S77-86.
3. Institute Brasileiro de Geografia e Estatística. Pesquisa de orcamentos familiares 2002-2003: análise da disponibilidade domiciliar de alimentos e do estado nutritional no Brasil. Rio de Janeiro (Brasil): IBGE; 2004.
4. Boeckner LS, Pullen CH, Walker SN, Oberdorfer MK, Hageman PA. Eating behaviors and health history of rural midlife to older women in the Midwestern United States. J Am Diet Assoc. 2007; 107:306-10.
5. Pérez-Bravo F, Carrasco E, Santos JL, Calvillán M, Larenas G, Albala C. Prevalence of type 2 diabetes and obesity in rural Mapuche population from Chile. Nutrition. 2001; 17:236-8.
6. Field A, Coakley EH, Must A, Spadano JL, Laird N, William H, et al. Impact of overweight on the risk of developing common chronic disease arlowduring a 10-year period. Arch Intern Med. 2001; 161:1581-6.
7. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff. 2007; 26:38-48.
8. Barroso SG, Abreu VG, Francischetti EA. A participação do tecido adiposo visceral na gênese da hipertensão arterial e doença cardiovascular aterogênica. Um conceito emergente. Arq Bras Cardiol. 2002;78:618-30.
9. Rizzo M, Corrado E, Coppola G, Muratori I, Novo S. Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. J Investig Med. 2008; 56:32-40.
10. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286:327-34.
11. Onat A, Can G, Hergenç G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism. 2008; 57:207-14.
12. Abdellaoui A, Al-Khaffaf H. C-reactive protein (CRP) as a marker in peripheral vascular disease. Eur J Vase Endovasc Surg. 2007; 34:18-22.
13. Yudkin JS, Knmari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000; 148:209-14.
14. Das UN. Is obesity an infiainmatory condition? Nutrition. 2001; 17:953-66.
15. Fain JN, Madan AK, Hiler ML, Cheeina P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004; 145:2273-82.
16. Mohamed-Ali V, Goodrick S, Rawaesh A, Mile JM, Katz DR, Yudkin JS, et al. Human subcutaneos adipose tissue releases IL-6 but not TNF-a in vivo. J Clin Endocrinol Metab. 1997; 82:4196-200.
17. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007; 56:1010-3.
18. Fogarty AW, Glancy C, Jones S, Lewis SA, McKeever TM, Britton JR. A prospective study of weight change and systemic inflammation over 9 y. Am J Clin Nutr. 2008; 87:30-5.
19. Gazzinelli A, Velasquez-Melendez G, Crawford SB, Lo Verde PT, Correa-Oliveira, R, Kloos H. Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Trop. 2006; 99:260-71.
20. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107:499-511.
21. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The seventh report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289:2560-72.
22. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Champaign: Human Kinetics Books; 1988.
23. World Health Organization. Physical Status: The use and interpretation of anthropometry. Geneva: WHO; 1995.
24. Friedewald WT, Levy, Al, Frederickson DS. Estimation of concentrations of low density cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.
25. Matthews DR, Hosker JP, Rudenski AS, Nay lor A, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985; 28:412-9.
26. Mahadik SR, Deo SS, Mehtalia SD. Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects. Metab Syndr Relat Disord. 2008; 6:121-8.
27. Festa A, D'Agostinho R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome - the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000; 102:42-7.
28. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282:2131-5.
29. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107:391-7.
30. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998; 128:127-37.
31. Venugopal SK, Devaraj S, Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens. 2005; 14:33-37.
32. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000; 102:2165-8.
33. Pasceri V, Cheng J, Willerson JT, Yeh ET. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drags. Circulation. 2001; 103:2531-4.
34. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plaminogen activator inihibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003; 107:398-404.
35. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MVA, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002; 106:913-9.
36. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003; 108:1676-8.
37. Wolbink GJ, Brouwer MC, Buysmann S, Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes. J Immunol. 1996; 157:473-9.
38. Fu T, Borensztajn J. Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. Biochem J. 2002; 366:195-201.
39. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol. 1999; 84:1018-22.
40. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol. 2005; 46:464-9.
41. Nakanishi N, Shiraishi T, Wada M. Association between C-reactive protein and insulin resistance in a Japanese population: the Minoh Study. Intern Med. 2005; 44:542-7.
42. Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance.......... the Chennai Urban Rural Epidemiology Study (CURES). Metabolism. 2006;55:1232-8.
43. Pannacciulli N, Cantatore FP, Minenna A, Bellacicco M, Giorgino R, De Pergola G C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Lit J Obes Relat Metab Disord. 2001; 25:1416-20.
44. García-Lorda P, Bulló M, Balanzà R, Salas-Salvadó J. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Lit J Obes. 2006; 30:468-74.
45. Nakamura H, Ito H, EgamiY, Kaji Y, MaruyamaT, Koike G, et al. Waist circumference is the main determinant of elevated C-reactive protein in metabolic syndrome. Diabetes Res Clin Pract. 2008; 79:330-6.
46. Rhee EU, Kim YC, Lee WY, Jung CM, Sung KC, Ryu SH, et al. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans. Metabolism. 2006; 55:83-7.